Docket Number:10A-1030805
Inventor:Jyh-Yih Chen, Chao-Yuan Yu, Chi-Hsien Chien
IP Status:TW I548415
Abstract:
We evaluated the efficacy of pardaxin as an anticancer drug in vivo in dogs with naturallyoccurring cancer (with fibrocarcinoma, with squamous cell carcinoma, with perianal gland adenoma, with histiocytoma, with malignant mast cell tumor, and with sarcoma).our report is the first to describe the use of an antimicrobial peptide as an anti-tumor agent in dog. We observed clear benefits of antimicrobial peptide therapy in dogs for which alternative treatment options, such as castration and tumor removal by surgery, were not available.
Fields of Application:
perianal gland adenomas 、 fibrosarcoma tumor、squamous cell carcinomas、malignant mast cell tumors.
Advantages when compared to the existing technologies:
To the best of our knowledge, our report is the first to describe the use of an antimicrobial peptide as an anti-tumor agent in dog. We observed clear benefits of antimicrobial peptide therapy in dogs for which alternative treatment options, such as castration and tumor removal by surgery, were not available.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
